Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint-Reference-Cited by-同舟云学术

Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint

Published:2023-01-04 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Liu Ying¹,Yingying Huang¹,Dongwang Zhu¹,Jiang Li¹,Tongchao Zhao¹,Yining He¹,Ronghui Xia¹,laiping Zhong¹

Affiliation:

1. Shanghai Jiao Tong University School of Medicine

Abstract

Abstract Background This study aimed to find out the characteristics in relation to tumor recurrence in diffused-tenosynovial giant cell tumor of temporomandibular joint and to develop and validate the prognostic model for personalized prediction. Methods From April 2009 to January 2021, patients with diffused-tenosynovial giant cell tumor of temporomandibular joint at a single center were included in this study. The clinical features and local recurrence-free survival were assessed through the expression of the Ki-67 index and colony-stimulating factor 1 receptor expression. Both univariate and multivariate analyses were performed on the prognostic factors for local recurrence-free survival. An independent predictor nomogram and pertinent tumor characteristics were included. Results The retrospective study enrolling seventy eligible patients at the Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine. During the follow-up time, eleven patients suffered tumor recurrence. Age was an independent risk factor for local recurrence-free survival (P = 0.032). The Ki-67 index varied significantly in different sites (P = 0.034) and tumor volume (P = 0.017). Multivariate logistic regression was used to develop the prediction model using both statistical significance and prognostic indicators. The C-index of the nomogram based on age, site, Ki-67, and colony-stimulating factor 1 receptor was 0.833. These variates provided good predicted accuracy for a nomogram on local recurrence-free survival. Diffused-tenosynovial giant cell tumor from the temporomandibular joint is extremely uncommon, and certain clinical traits are linked to the tumor proliferation index. Conclusions We identified the risk indicators and developed a nomogram in this study to forecast the likelihood of local recurrence-free survival in patients with diffused-tenosynovial giant cell tumor from temporomandibular joint.

Publisher

Research Square Platform LLC

Reference25 articles.

1. Higher incidence rates than previously known in tenosynovial giant cell tumors;Mastboom MJL;Acta Orthop,2017

2. Gouin F, Noailles T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis). Orthopaedics & traumatology, surgery & research OTSR 2017;103(1S):S91-S97.

3. Treatments of tenosynovial giant cell tumors of the temporomandibular joint: a report of three cases and a review of the literature;Verspoor FGM;Int J Oral Maxillofac Surg,2018

4. Diagnosis and treatment of diffuse tenosynovial giant cell tumor arising from temporomandibular joints. Beijing da xue xue bao;Meng JH;J Peking Univ Health Sci,2016

5. Wang J-G, Liu J, He B, Gao L, Zhang L, Liu J. Diffuse Tenosynovial Giant Cell Tumor Around the Temporomandibular Joint: An Entity With Special Radiologic and Pathologic Features. Journal of oral and maxillofacial surgery official journal of the American Association of Oral and Maxillofacial Surgeons 2019;77(5):1022.e1-1022.e39.